Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Psychedelics Business

News
Former NHL Player Launches Psychedelics Company
01/25/2021
Former NHL player Daniel Carcillo has founded Wesana Health, an emerging life sciences company that will focus on developing psychedelic-assisted therapies to treat traumatic brain injuries.
Former NHL player Daniel Carcillo has founded Wesana Health, an emerging life sciences company that will focus on developing psychedelic-assisted therapies to treat traumatic brain injuries.
Former NHL player Daniel...
01/25/2021
Behavioral Healthcare Executive
News
atai Acquires Firm Developing Schizophrenia Treatment, Plans IPO
01/21/2021
atai Life Sciences, a clinical-stage biopharmaceutical firm backed by Peter Thiel and other investors, recently acquired a majority stake in Recognify Life Sciences. Recognify is developing a treatment for cognitive impairment associated...
atai Life Sciences, a clinical-stage biopharmaceutical firm backed by Peter Thiel and other investors, recently acquired a majority stake in Recognify Life Sciences. Recognify is developing a treatment for cognitive impairment associated...
atai Life Sciences, a...
01/21/2021
Behavioral Healthcare Executive
News
Mind Cure to Acquire Ownership Interest in Psychedelic-Assisted Therapy Treatment Center
01/13/2021
Mind Cure Health, a Vancouver, British Columbia-based mental health firm, announced this week that it has signed a letter of intent to acquire an ownership interest in ATMA Journey Centers, a Calgary, Alberta-based treatment center that...
Mind Cure Health, a Vancouver, British Columbia-based mental health firm, announced this week that it has signed a letter of intent to acquire an ownership interest in ATMA Journey Centers, a Calgary, Alberta-based treatment center that...
Mind Cure Health, a Vancouver,...
01/13/2021
Behavioral Healthcare Executive
News
COMPASS Pathways, Sheppard Pratt Collaborate on Research Facility
01/12/2021
London-based COMPASS Pathways and the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore announced that the two organizations are collaborating on a “Centre of Excellence” that will serve as a research facility...
London-based COMPASS Pathways and the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore announced that the two organizations are collaborating on a “Centre of Excellence” that will serve as a research facility...
London-based COMPASS Pathways...
01/12/2021
Behavioral Healthcare Executive
News
Novamind Begins Trading Shares on Canadian Exchange
01/05/2021
Novamind, a Toronto-based mental health company that specializes in psychedelic-assisted therapy, announced that common shares of the company were to begin trading on the Canadian Securities Exchange on Tuesday.
Novamind, a Toronto-based mental health company that specializes in psychedelic-assisted therapy, announced that common shares of the company were to begin trading on the Canadian Securities Exchange on Tuesday.
Novamind, a Toronto-based mental...
01/05/2021
Behavioral Healthcare Executive

Advertisement

Stay in the Know

Behavioral Healthcare Executive Newsletter

Popular Articles

Ron Manderscheid, PhD
Perspectives
Social Isolation Epidemic Must Be Confronted Head-On
05/18/2023
Ron Manderscheid, PhD
With a rise in loneliness putting the nation at an increased risk of depression, anxiety, and substance use, US Surgeon General Vivek Murthy, MD, has proposed a national strategy for improving social connection.
With a rise in loneliness putting the nation at an increased risk of depression, anxiety, and substance use, US Surgeon General Vivek Murthy, MD, has proposed a national strategy for improving social connection.
With a rise in loneliness...
05/18/2023
Behavioral Healthcare Executive
Rosalynn Carter: Stigma has `a long way to go`
01/23/2013
Former First Lady reflects 40-plus years of fighting stigma, advocating for those with mental illnesses, in this exclusive interview.
Former First Lady reflects 40-plus years of fighting stigma, advocating for those with mental illnesses, in this exclusive interview.
Former First Lady reflects...
01/23/2013
Behavioral Healthcare Executive
News
Rogers to be Honored for Leadership in Combating Opioid Epidemic
10/22/2019
U.S. Rep. Hal Rogers, the Kentucky Congressman who has led various federal initiatives to combat the opioid epidemic, will be honored on Wednesday in Washington, D.C., by Mothers Against Prescription Drug Abuse (MAPDA) with the organization’s...
U.S. Rep. Hal Rogers, the Kentucky Congressman who has led various federal initiatives to combat the opioid epidemic, will be honored on Wednesday in Washington, D.C., by Mothers Against Prescription Drug Abuse (MAPDA) with the organization’s...
U.S. Rep. Hal Rogers, the...
10/22/2019
Behavioral Healthcare Executive
News
AMA Releases Full Language of New CPT Code for Psychedelic Therapies
07/06/2023
Tom Valentino, Digital Managing Editor
The new Current Procedural Terminology III code for continuous in-person monitoring and intervention during psychedelic medication therapy will go into effect on January 1, 2024.
The new Current Procedural Terminology III code for continuous in-person monitoring and intervention during psychedelic medication therapy will go into effect on January 1, 2024.
The new Current Procedural...
07/06/2023
Behavioral Healthcare Executive
News
Americans support coverage of all levels of care for mental and addictive disorders, survey says
12/18/2012
A national study conducted by Public Opinion Strategies for the National Association of Psychiatric Health Systems (NAPHS) says that 93% of Americans agree that these types of services should be covered.
A national study conducted by Public Opinion Strategies for the National Association of Psychiatric Health Systems (NAPHS) says that 93% of Americans agree that these types of services should be covered.
A national study conducted by...
12/18/2012
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement